Traumatic injury results in prolonged circulation of ultralarge von Willebrand factor and a reduction in ADAMTS13 activity

Increases in plasma von Willebrand Factor (VWF) levels, accompanied by decreases in the metalloprotease ADAMTS13, have been demonstrated soon after traumatic injury while downstream effects remain unclear.

• Publication year

  2020

• Venue

  Transfusion

• Publication date

  2020-05-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/trf.15856PMID 32441353
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock

  2018cited by this paper
• ADAMTS13: origins, applications, and prospects

  2018cited by this paper
• Low Plasma ADAMTS13 Activity Is Associated with Coagulopathy, Endothelial Cell Damage and Mortality after Severe Paediatric Trauma

  2018cited by this paper
• The Role of von Willebrand Factor, ADAMTS13, and Cerebral Artery Thrombus Composition in Patient Outcome Following Mechanical Thrombectomy for Acute Ischemic Stroke

  2018cited by this paper
• Quantitative Analysis of Von Willebrand Factor (VWF) Multimers in Von Willebrand Disease (VWD) Patients Recruited through the Zimmerman Program for the Molecular and Clinical Biology of VWD

  2017cited by this paper
• Acute traumatic coagulopathy and trauma-induced coagulopathy: an overview

  2017cited by this paper
• Validation of a panel of ADAMTS13 assays for diagnosis of thrombotic thrombocytopenic purpura: activity, functional inhibitor, and autoantibody test

  2016cited by this paper
• Advances in the understanding of trauma-induced coagulopathy.

  2016cited by this paper
• Plasma Resuscitation Promotes Coagulation Homeostasis Following Shock-Induced Hypercoagulability

  2016cited by this paper
• Procoagulant and fibrinolytic activity after polytrauma in rat.

  2016cited by this paper
• Novel markers predict death and organ failure following hemorrhagic shock.

  2015cited by this paper
• Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial.

  2015cited by this paper
• Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock

  2015cited by this paper
• Clinical assessment of trauma-induced coagulopathy and its contribution to postinjury mortality: A TACTIC proposal.

  2015cited by this paper
• Relevance of ADAMTS13 to liver transplantation and surgery.

  2015cited by this paper
• Epidemiology of severe trauma.

  2014cited by this paper
• Increasing Trauma Deaths in the United States

  2014cited by this paper
• Of von Willebrand factor and platelets

  2014cited by this paper
• Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis

  2014cited by this paper
• Plasmatic ADAMTS-13 metalloprotease and von Willebrand factor in children with cyanotic congenital heart disease

  2013cited by this paper
• Coagulopathy after traumatic brain injury: incidence, pathogenesis, and treatment options

  2013cited by this paper
• An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: Implications for hemostasis and clinical outcome

  2013cited by this paper
• Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis

  2012cited by this paper
• Critical Role of Activated Protein C in Early Coagulopathy and Later Organ Failure, Infection and Death in Trauma Patients

  2012cited by this paper
• Early coagulopathy in trauma patients: an on-scene and hospital admission study.

  2012cited by this paper
• Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations

  2010cited by this paper
• Inactivation of ADAMTS13 by plasmin as a potential cause of thrombotic thrombocytopenic purpura

  2010cited by this paper
• TRANSFUSION PRACTICE: Thrombin generation in trauma patients

  2009cited by this paper
• Epidemiology of major trauma

  2009cited by this paper
• Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells

  2008cited by this paper
• Extensive contacts between ADAMTS13 exosites and von Willebrand factor domain A2 contribute to substrate specificity.

  2008cited by this paper
• Neurological Disorders: Public Health Challenges

  2007cited by this paper
• Projections of Global Mortality and Burden of Disease from 2002 to 2030

  2006cited by this paper
• Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure.

  2006cited by this paper
• Proteolytic inactivation of ADAMTS13 by thrombin and plasmin.

  2005cited by this paper
• Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers.

  2005cited by this paper
• Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutations

  2004cited by this paper
• Early coagulopathy predicts mortality in trauma.

  2003cited by this paper
• Shear Stress and von Willebrand Factor in Health and Disease

  2003cited by this paper
• Acute traumatic coagulopathy.

  2003cited by this paper
• Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers.

  2002cited by this paper
• Plasma and Platelet von Willebrand Factor Abnormalities in Patients With Uremia: Lack of Correlation With Uremic Bleeding

  2001cited by this paper
• Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP.

  2000cited by this paper
• Haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura--new insights into underlying biochemical mechanisms.

  2000cited by this paper
• Glycoprotein Ib-V-IX, a Receptor for von Willebrand Factor, Couples Physically and Functionally to the Fc Receptor γ-Chain, Fyn, and Lyn to Activate Human Platelets

  1999cited by this paper
• Glycoprotein Ib-V-IX, a receptor for von Willebrand factor, couples physically and functionally to the Fc receptor gamma-chain, Fyn, and Lyn to activate human platelets.

  1999cited by this paper
• 16 Deficiency of von Willebrand factor-cleaving protease in familial and acquired thrombotic thrombocytopenic purpura

  1998cited by this paper
• Deficiency of von Willebrand factor-cleaving protease in familial and acquired thrombotic thrombocytopenic purpura.

  1998cited by this paper
• von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?

  1997cited by this paper
• Epidemiology of trauma deaths: a reassessment.

  1993cited by this paper
• PROTEOLYTIC DEGRADATION OF VON WILLEBRAND FACTOR AFTER DDAVP ADMINISTRATION IN NORMAL INDIVIDUALS

  1987cited by this paper

• The relationships between disseminated intravascular coagulation and time series change of Von Willebrand factor in patients with out-of-hospital cardiac arrest: a retrospective observational study.

  2026cites this paper
• Dried plasma retains hemostatic function and thermal stability during Arctic military operations.

  2025cites this paper
• Hemostatic abnormalities after trauma resuscitation: challenges and strategies in caring for the critically injured patient

  2025cites this paper
• A novel role for ADAMTS13 in hyperfibrinolysis after trauma-induced shock☆.

  2025cites this paper
• Perioperative Profiling of a Disintegrin and Metalloprotease with Thrombospondin Type 1 Motif, Member 13 (ADAMTS13) Activity in Cardiac Surgery: Kinetics and Mechanistic Insights

  2025cites this paper
• Trauma-Induced Coagulopathy: A Review of Specific Molecular Mechanisms

  2025cites this paper
• N-acetylcysteine reduces von Willebrand factor multimer size and improves renal microvascular blood flow in rats after severe trauma.

  2025cites this paper
• Injury induced endotheliopathy: overview, diagnosis, and management.

  2025cites this paper
• Freeze‐dried plasma: Hemostasis and biophysical analyses for damage control resuscitation

  2025influential citation
• Therapeutic plasma exchange is feasible and tolerable in severely injured patients with trauma-induced coagulopathy

  2024cites this paper
• Perioperative management of patients with hemostatic system disorders. Methodological recommendations of the All-Russian public organization “Federation of Anesthesiologists and Reanimatologists” and the National Association of Specialists in Thrombosis, Clinical Hemostasiology and Hemorheology

  2024cites this paper
• Efficacy and safety of novel freeze‐dried plasma products in a porcine combat casualty model

  2024cites this paper
• Immediate use cryoprecipitate products provide lasting organ protection in a rodent model of trauma/hemorrhagic shock and prolonged hypotensive resuscitation

  2023cites this paper
• Surgical Science and the Evolution of Critical Care Medicine

  2023influential citation
• Early lyophilized cryoprecipitate enhances the ADAMTS13/VWF ratio to reduce systemic endotheliopathy and lessen lung injury in a mouse multiple-trauma hemorrhage model

  2023cites this paper
• Injury-Induced Endotheliopathy: What You Need to Know.

  2023cites this paper
• Thrombotic microangiopathy after traumatic brain injury: A case report and review of the literature

  2023cites this paper
• The intersection of coagulation activation and inflammation after injury: What you need to know

  2023cites this paper
• Effect of tranexamic acid on endothelial von Willebrand factor/ADAMTS-13 response to in vitro shock conditions

  2022cites this paper
• Platelet Transfusion for Trauma Resuscitation

  2022cites this paper
• Platelet dysfunction after trauma: From mechanisms to targeted treatment

  2022cites this paper
• Von Willebrand Factor and Platelet Aggregation: from Bench to Clinical Practice

  2022cites this paper
• Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19

  2021cites this paper
• Quantification of von Willebrand factor and ADAMTS-13 after traumatic injury: a pilot study

  2021cites this paper
• Plasma and rhADAMTS13 reduce trauma-induced organ failure by restoring the ADAMTS13-VWF axis.

  2021cites this paper
• Plasma as a resuscitation fluid for volume‐depleted shock: Potential benefits and risks

  2021cites this paper
• Trauma-induced coagulopathy

  2021cites this paper
• VAMP3 and SNAP23 as Potential Targets for Preventing the Disturbed Flow-Accelerated Thrombus Formation

  2020cites this paper
• Role of von Willebrand Factor after Injury: It may do More than we Think.

  2020cites this paper
• Diverse activities of von Willebrand factor in traumatic brain injury and associated coagulopathy

  2020cites this paper